AGILE THERAPEUTICS, INC. Shares of Common Stock (par value $0.0001 per share) Sales AgreementAgile Therapeutics Inc • April 27th, 2022 • Pharmaceutical preparations
Agile Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Agent”), as follows:
